Direct letters to relatives at risk of hereditary cancer – study protocol for a multi-centre randomised controlled trial of healthcare-assisted versus family-mediated risk disclosure at Swedish cancer genetics clinics (DIRECT-study)
Carolina Hawranek(Umeå University), Anna Rosén(Unknown), Hans Ehrencrona(Lund University), Barbro Numan Hellquist(Umeå University), Anna Öfverholm(Swedish Institute)
Cited by 2
Related Papers
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian Cancer
|JAMA|2015|513
Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in <i>RAD51C</i> and <i>RAD51D</i>
|JNCI Journal of the National Cancer Institute|2020|163
Comprehensive molecular comparison of BRCA1 hypermethylated and BRCA1 mutated triple negative breast cancers
|Nature Communications|2020|141
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
|PLoS Genetics|2014|130
Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers
|Human Molecular Genetics|2009|116